ERBB2 and gastric cancer: The standard chemotherapy for advanced GC has been almost unified worldwide: a combination of fluoropyrimidine and platinum compounds, with trastuzumab added for HER2-positive GC, in a first-line (1L) setting and paclitaxel with or without ramucirumab in a second-line (2L) setting [39,40,60].